Over-activation of YAP/TAZ through aberrant regulation of Hippo has been noted in many types of tumors and associated with the acquisition of malignant traits, including resistance to anticancer therapies, the maintenance of cancer stemness, distant metastasis [4], and in prostates, androgen-independent (AI) adenocarcinoma progression [13,14]. The gene discussed is YAP1; the disease is cancer.